Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 2 Μαΐ 2022 · New York Medical Treatment Guidelines, Effective May 2, 2022. Below are new editions of the New York Medical Treatment Guidelines effective for dates of treatment on or after May 2, 2022. New York Ankle and Foot Disorders. New York Elbow Injuries.

  2. A. General Guideline Principles. The principles summarized in this section are key to the intended application of the New York State Medical Treatment Guidelines (MTG) and are applicable to all Workers’ Compensation Medical Treatment Guidelines.

  3. The Chair has adopted amendments to 12 NYCRR 324.2, incorporating three new New York Medical Treatment Guidelines (MTGs) by reference: New York Eye Disorders Medical Treatment Guidelines. New York Traumatic Brain Injury Medical Treatment Guidelines.

  4. 3 Σεπ 2024 · ACLS guidelines: Loading dose: Infuse 20 mg/minute (up to 50 mg/minute for more urgent situations) until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of its original width, or total of 17 mg/kg is given.

  5. 8 Μαΐ 2023 · Procainamide is given IV or PO with the onset of action in 10 to 30 minutes. The loading dose is of IV procainamide is 10 to 17 mg/kg and administered at a rate of 20 to 50 mg/min. Alternatively, this may be dosed at 100 mg every 5 minutes in adult patients.

  6. www.aclsonline.us › drugs › procainamideProcainamide in ACLS

    In ACLS, procainamide is indicated for the treatment of stable ventricular tachycardia. However, it can also be used in the treatment of AF with RVR including AF caused by WPW. The main side effect of procainamide is hypotension due to decreased inotropy.

  7. Adult Dosage for Procainamide: The use of procainamide is limited in ACLS for cardiac arrest, due to its requirement of slow infusion and its somewhat unknown effectiveness. If used for recurrent ventricular fibrillation and pulseless ventricular tachycardia, 20 mg/min should be given via IV infusion to a total dose of 17 mg/kg.